Biomerica, Inc. (BMRA)
USD 0.29
(-7.62%)
USD 0.29
(-7.62%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 785 Thousand USD | -27.45% |
| 2023 | 1.08 Million USD | -21.57% |
| 2022 | 1.37 Million USD | -14.82% |
| 2021 | 1.61 Million USD | -9.09% |
| 2020 | 1.78 Million USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | -100.0% |
| 2012 | 43 Thousand USD | 21.5% |
| 2011 | 35.39 Thousand USD | -56.04% |
| 2010 | 80.49 Thousand USD | -0.03% |
| 2009 | 80.52 Thousand USD | -62.49% |
| 2008 | 214.68 Thousand USD | 21.67% |
| 2007 | 176.44 Thousand USD | -35.42% |
| 2006 | 273.23 Thousand USD | -42.61% |
| 2005 | 476.08 Thousand USD | 50.03% |
| 2004 | 317.31 Thousand USD | 1.06% |
| 2003 | 313.97 Thousand USD | -28.75% |
| 2002 | 440.66 Thousand USD | 87.52% |
| 2001 | 235 Thousand USD | 46.88% |
| 2000 | 160 Thousand USD | -20.0% |
| 1999 | 200 Thousand USD | 100.0% |
| 1998 | 100 Thousand USD | -75.0% |
| 1997 | 400 Thousand USD | -50.0% |
| 1996 | 800 Thousand USD | -38.46% |
| 1995 | 1.3 Million USD | -27.78% |
| 1994 | 1.8 Million USD | -18.18% |
| 1993 | 2.2 Million USD | -4.35% |
| 1992 | 2.3 Million USD | -14.81% |
| 1991 | 2.7 Million USD | -3.57% |
| 1990 | 2.8 Million USD | 0.0% |
| 1989 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 FY | 785 Thousand USD | -27.45% |
| 2024 Q4 | 785 Thousand USD | -8.93% |
| 2024 Q3 | 862 Thousand USD | -8.0% |
| 2024 Q1 | 1.01 Million USD | -6.56% |
| 2024 Q2 | 937 Thousand USD | -7.32% |
| 2023 Q2 | 1.24 Million USD | -5.05% |
| 2023 Q1 | 1.31 Million USD | -4.7% |
| 2023 FY | 1.08 Million USD | -21.57% |
| 2023 Q4 | 1.08 Million USD | -8.18% |
| 2023 Q3 | 1.17 Million USD | -5.61% |
| 2022 Q1 | 1.56 Million USD | -3.44% |
| 2022 Q4 | 1.37 Million USD | -4.42% |
| 2022 FY | 1.37 Million USD | -14.82% |
| 2022 Q2 | 1.5 Million USD | -3.94% |
| 2022 Q3 | 1.44 Million USD | -3.92% |
| 2021 Q4 | 1.61 Million USD | -0.34% |
| 2021 FY | 1.61 Million USD | -9.09% |
| 2021 Q1 | 1.73 Million USD | -2.8% |
| 2021 Q2 | 1.67 Million USD | -3.05% |
| 2021 Q3 | 1.62 Million USD | -3.2% |
| 2020 FY | 1.78 Million USD | 0.0% |
| 2020 Q1 | 1.92 Million USD | 0.0% |
| 2020 Q2 | 1.87 Million USD | -2.46% |
| 2020 Q3 | 1.83 Million USD | -2.57% |
| 2020 Q4 | 1.78 Million USD | -2.68% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | -100.0% |
| 2013 FY | - USD | -100.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2012 Q3 | - USD | -100.0% |
| 2012 Q1 | 23.66 Thousand USD | -33.13% |
| 2012 FY | 43 Thousand USD | 21.5% |
| 2012 Q2 | 11.74 Thousand USD | -50.38% |
| 2012 Q4 | 43 Thousand USD | 0.0% |
| 2011 FY | 35.39 Thousand USD | -56.04% |
| 2011 Q1 | 69.45 Thousand USD | -13.71% |
| 2011 Q2 | 58.37 Thousand USD | -15.96% |
| 2011 Q3 | 46.94 Thousand USD | -19.57% |
| 2011 Q4 | 35.39 Thousand USD | -24.62% |
| 2010 Q2 | 43.6 Thousand USD | 1.61% |
| 2010 Q1 | 42.91 Thousand USD | -46.71% |
| 2010 FY | 80.49 Thousand USD | -0.03% |
| 2010 Q3 | 91.34 Thousand USD | 109.48% |
| 2010 Q4 | 80.49 Thousand USD | -11.87% |
| 2009 Q1 | 154.72 Thousand USD | -27.93% |
| 2009 Q4 | 80.52 Thousand USD | -40.01% |
| 2009 FY | 80.52 Thousand USD | -62.49% |
| 2009 Q2 | 90.14 Thousand USD | -41.74% |
| 2009 Q3 | 134.22 Thousand USD | 48.91% |
| 2008 Q2 | 325.77 Thousand USD | 102.92% |
| 2008 Q3 | 308.18 Thousand USD | -5.4% |
| 2008 Q4 | 214.68 Thousand USD | -30.34% |
| 2008 FY | 214.68 Thousand USD | 21.67% |
| 2008 Q1 | 160.54 Thousand USD | -9.01% |
| 2007 Q2 | 252.62 Thousand USD | -2.93% |
| 2007 Q4 | 176.44 Thousand USD | -27.68% |
| 2007 Q1 | 260.24 Thousand USD | -4.75% |
| 2007 FY | 176.44 Thousand USD | -35.42% |
| 2007 Q3 | 243.99 Thousand USD | -3.42% |
| 2006 Q4 | 273.23 Thousand USD | 2.1% |
| 2006 Q1 | 320.02 Thousand USD | -32.78% |
| 2006 Q2 | 849.03 Thousand USD | 165.3% |
| 2006 Q3 | 267.6 Thousand USD | -68.48% |
| 2006 FY | 273.23 Thousand USD | -42.61% |
| 2005 Q3 | 512.73 Thousand USD | 9.72% |
| 2005 FY | 476.08 Thousand USD | 50.03% |
| 2005 Q2 | 467.31 Thousand USD | 47.27% |
| 2005 Q1 | 317.31 Thousand USD | 0.0% |
| 2005 Q4 | 476.08 Thousand USD | -7.15% |
| 2004 Q3 | 101.93 Thousand USD | -68.5% |
| 2004 FY | 317.31 Thousand USD | 1.06% |
| 2004 Q2 | 323.58 Thousand USD | -4.34% |
| 2004 Q1 | 338.25 Thousand USD | 7.73% |
| 2004 Q4 | 317.31 Thousand USD | 211.31% |
| 2003 Q3 | 328.72 Thousand USD | 2.73% |
| 2003 Q1 | 338.85 Thousand USD | -23.1% |
| 2003 Q2 | 320 Thousand USD | -5.57% |
| 2003 Q4 | 313.97 Thousand USD | -4.49% |
| 2003 FY | 313.97 Thousand USD | -28.75% |
| 2002 Q1 | 385 Thousand USD | 63.83% |
| 2002 Q2 | 432.84 Thousand USD | 12.43% |
| 2002 Q3 | 427.18 Thousand USD | -1.31% |
| 2002 Q4 | 440.66 Thousand USD | 3.16% |
| 2002 FY | 440.66 Thousand USD | 87.52% |
| 2001 Q2 | 723 Thousand USD | -20.55% |
| 2001 Q4 | 235 Thousand USD | -10.65% |
| 2001 Q3 | 263 Thousand USD | -63.62% |
| 2001 FY | 235 Thousand USD | 46.88% |
| 2001 Q1 | 910 Thousand USD | 468.75% |
| 2000 FY | 160 Thousand USD | -20.0% |
| 2000 Q1 | 200 Thousand USD | 0.0% |
| 2000 Q2 | 200 Thousand USD | 0.0% |
| 2000 Q4 | 160 Thousand USD | -27.27% |
| 2000 Q3 | 220 Thousand USD | 10.0% |
| 1999 Q3 | 200 Thousand USD | 0.0% |
| 1999 Q4 | 200 Thousand USD | 0.0% |
| 1999 Q2 | 200 Thousand USD | 100.0% |
| 1999 Q1 | 100 Thousand USD | 0.0% |
| 1999 FY | 200 Thousand USD | 100.0% |
| 1998 Q4 | 100 Thousand USD | -50.0% |
| 1998 FY | 100 Thousand USD | -75.0% |
| 1998 Q1 | 300 Thousand USD | -25.0% |
| 1998 Q2 | 300 Thousand USD | 0.0% |
| 1998 Q3 | 200 Thousand USD | -33.33% |
| 1997 Q1 | 700 Thousand USD | -12.5% |
| 1997 FY | 400 Thousand USD | -50.0% |
| 1997 Q4 | 400 Thousand USD | 33.33% |
| 1997 Q3 | 300 Thousand USD | 0.0% |
| 1997 Q2 | 300 Thousand USD | -57.14% |
| 1996 Q1 | 1.2 Million USD | -7.69% |
| 1996 Q4 | 800 Thousand USD | 14.29% |
| 1996 Q3 | 700 Thousand USD | -12.5% |
| 1996 FY | 800 Thousand USD | -38.46% |
| 1996 Q2 | 800 Thousand USD | -33.33% |
| 1995 Q4 | 1.3 Million USD | 0.0% |
| 1995 FY | 1.3 Million USD | -27.78% |
| 1995 Q2 | 1.4 Million USD | -12.5% |
| 1995 Q3 | 1.3 Million USD | -7.14% |
| 1995 Q1 | 1.6 Million USD | -11.11% |
| 1994 Q1 | 2.1 Million USD | -4.55% |
| 1994 Q2 | 2 Million USD | -4.76% |
| 1994 FY | 1.8 Million USD | -18.18% |
| 1994 Q3 | 1.9 Million USD | -5.0% |
| 1994 Q4 | 1.8 Million USD | -5.26% |
| 1993 Q2 | 2 Million USD | -13.04% |
| 1993 Q4 | 2.2 Million USD | 10.0% |
| 1993 FY | 2.2 Million USD | -4.35% |
| 1993 Q1 | 2.3 Million USD | 0.0% |
| 1993 Q3 | 2 Million USD | 0.0% |
| 1992 Q3 | 2.5 Million USD | -10.71% |
| 1992 Q2 | 2.8 Million USD | 0.0% |
| 1992 Q4 | 2.3 Million USD | -8.0% |
| 1992 FY | 2.3 Million USD | -14.81% |
| 1992 Q1 | 2.8 Million USD | 3.7% |
| 1991 FY | 2.7 Million USD | -3.57% |
| 1991 Q4 | 2.7 Million USD | -3.57% |
| 1991 Q3 | 2.8 Million USD | 12.0% |
| 1991 Q2 | 2.5 Million USD | 0.0% |
| 1991 Q1 | 2.5 Million USD | -10.71% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 Q4 | 2.8 Million USD | 0.0% |
| 1990 FY | 2.8 Million USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 541.67 Million USD | 99.855% |
| Nemaura Medical Inc. | 20.03 Million USD | 96.081% |
| NeuroPace, Inc. | 72.39 Million USD | 98.916% |
| LENSAR, Inc. | 2.3 Million USD | 66.003% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | 89.314% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | 50.784% |
| Apyx Medical Corporation | 38.5 Million USD | 97.961% |
| Cutera, Inc. | 431.91 Million USD | 99.818% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | 94.979% |
| BioSig Technologies, Inc. | 452 Thousand USD | -73.673% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | 97.998% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 99.953% |
| Axonics, Inc. | 27.61 Million USD | 97.158% |
| IRIDEX Corporation | 2.74 Million USD | 71.413% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 99.009% |
| TELA Bio, Inc. | 42.78 Million USD | 98.165% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -112.737% |
| RxSight, Inc. | 3.01 Million USD | 73.938% |
| Align Technology, Inc. | 96.96 Million USD | 99.19% |
| INVO Bioscience, Inc. | 8.68 Million USD | 90.96% |
| electroCore, Inc. | 626 Thousand USD | -25.399% |
| Telesis Bio, Inc. | 34.38 Million USD | 97.717% |
| Viemed Healthcare, Inc. | 10.27 Million USD | 92.357% |
| Quipt Home Medical Corp. | 98.94 Million USD | 99.207% |
| Anika Therapeutics, Inc. | 29.03 Million USD | 97.297% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 66.567% |
| Lucid Diagnostics Inc. | 15.25 Million USD | 94.854% |
| Dynatronics Corporation | 6.68 Million USD | 88.262% |
| Modular Medical, Inc. | 1.19 Million USD | 34.034% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -199.618% |
| Talis Biomedical Corporation | 19.66 Million USD | 96.009% |
| PetVivo Holdings, Inc. | 1.36 Million USD | 42.493% |
| InMode Ltd. | 9.01 Million USD | 91.294% |
| Envoy Medical, Inc. | 404 Thousand USD | -94.307% |
| Bruker Corporation | 1.37 Billion USD | 99.943% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -1277.193% |
| DexCom, Inc. | 2.59 Billion USD | 99.97% |
| Nexalin Technology, Inc. | 4463.00 USD | -17489.066% |
| PAVmed Inc | 48.72 Million USD | 98.389% |
| Viveve Medical, Inc. | 5.34 Million USD | 85.324% |
| Cerus Corporation | 95.99 Million USD | 99.182% |
| Movano Inc. | 252 Thousand USD | -211.508% |
| Cytek Biosciences, Inc. | 33.17 Million USD | 97.634% |
| Nexalin Technology, Inc. | 4463.00 USD | -17489.066% |
| IceCure Medical Ltd | 599 Thousand USD | -31.052% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 99.811% |
| enVVeno Medical Corporation | 1.4 Million USD | 44.009% |
| 908 Devices Inc. | 5.94 Million USD | 86.796% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | 94.369% |
| Orthofix Medical Inc. | 134.19 Million USD | 99.415% |
| Surmodics, Inc. | 29.4 Million USD | 97.33% |
| Nuwellis, Inc. | 981 Thousand USD | 19.98% |
| Outset Medical, Inc. | 136.18 Million USD | 99.424% |
| Venus Concept Inc. | 79.69 Million USD | 99.015% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 99.395% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 98.883% |
| Nano-X Imaging Ltd. | 8.39 Million USD | 90.65% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | 16.517% |
| Inogen, Inc. | 21.92 Million USD | 96.419% |
| IRadimed Corporation | 2.04 Million USD | 61.577% |
| MaxCyte, Inc. | 18.74 Million USD | 95.812% |
| Pulmonx Corporation | 41.42 Million USD | 98.105% |
| PAVmed Inc. | 48.72 Million USD | 98.389% |
| iCAD, Inc. | 461 Thousand USD | -70.282% |
| OrthoPediatrics Corp. | 23.76 Million USD | 96.696% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | 60.681% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -59.556% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -325.705% |
| SI-BONE, Inc. | 38.99 Million USD | 97.987% |
| Semler Scientific, Inc. | 70 Thousand USD | -1021.429% |
| Beyond Air, Inc. | 17.83 Million USD | 95.599% |
| FONAR Corporation | 41.67 Million USD | 98.116% |
| AxoGen, Inc. | 69.29 Million USD | 98.867% |
| Biotricity, Inc. | 23.87 Million USD | 96.713% |
| Cytosorbents Corporation | 18.31 Million USD | 95.713% |
| ZimVie Inc. | 521.92 Million USD | 99.85% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 98.442% |
| Inari Medical, Inc. | 32.04 Million USD | 97.55% |
| UFP Technologies, Inc. | 46.03 Million USD | 98.295% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | 60.681% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | 74.439% |
| Sight Sciences, Inc. | 35.41 Million USD | 97.783% |
| Insulet Corporation | 1.44 Billion USD | 99.946% |
| Profound Medical Corp. | 7.9 Million USD | 90.064% |
| Bioventus Inc. | 409.47 Million USD | 99.808% |
| InspireMD, Inc. | 1.59 Million USD | 50.784% |
| BrainsWay Ltd. | 471 Thousand USD | -66.667% |
| BIOLASE, Inc. | 17.91 Million USD | 95.617% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | 24.253% |
| Tenon Medical, Inc. | 1.17 Million USD | 33.078% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | 21.657% |
| CVRx, Inc. | 30.61 Million USD | 97.436% |
| AdaptHealth Corp. | 2.29 Billion USD | 99.966% |
| Sintx Technologies, Inc. | 4.24 Million USD | 81.508% |
| Acutus Medical, Inc. | 38.47 Million USD | 97.96% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | 60.652% |
| NanoVibronix, Inc. | 5000.00 USD | -15600.0% |
| Quanterix Corporation | 41.46 Million USD | 98.107% |
| LivaNova PLC | 640.4 Million USD | 99.877% |
| Co-Diagnostics, Inc. | 2.99 Million USD | 73.751% |
| Varex Imaging Corporation | 469.5 Million USD | 99.833% |
| Vivani Medical, Inc. | 20.69 Million USD | 96.207% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 66.567% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -0.255% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 99.916% |
| TransMedics Group, Inc. | 515.94 Million USD | 99.848% |
| ReWalk Robotics Ltd. | 1.9 Million USD | 58.749% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -225.894% |
| Spectral AI, Inc. | 1.28 Million USD | 39.1% |
| Hyperfine, Inc. | 185 Thousand USD | -324.324% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 99.592% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -74.645% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -112.102% |
| Silk Road Medical, Inc | 84.63 Million USD | 99.072% |